Lifecore Biomedical share price today

(LFCR)

Lifecore Biomedical share price is $7.6 & ₹647.50 as on 25 Dec 2024, 2.30 'hrs' IST

$7.6

▲

0.57

(8.11%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Lifecore Biomedical share price in Dollar and Rupees. Guide to invest in Lifecore Biomedical from India. Also see the sentimental analysis on Indian investors investing in Lifecore Biomedical. Get details on the Indian mutual funds that are investing in Lifecore Biomedical. Get Analyst recommendations and forecasts along with all the Lifecore Biomedical's financials.

Lifecore Biomedical share price movements

Today's Low: $6.93
Today's High: $7.63
$7.60
8.88%
Downside
Day's Volatility :9.24%
Upside
0.39%
52 Weeks Low: $3.68
52 Weeks High: $8.90
$7.60
51.59%
Downside
52 Weeks Volatility :58.66%
Upside
14.61%

Lifecore Biomedical Returns

Period	Lifecore Biomedical Inc	Index (Russel 2000)
3 Months	61.02%	0.0%
6 Months	47.86%	0.0%
1 Year	21.21%	0.0%
3 Years	-31.78%	-21.1%

Lifecore Biomedical Key Statistics

in dollars & INR

Previous Close	$7.03
Open	$7.13
Today's High	$7.63
Today's Low	$6.925
Market Capitalization	$279.9M
Today's Volume	$247.4K
52 Week High	$8.9
52 Week Low	$3.6793
Revenue TTM	$128.4M
EBITDA	$-674.0K
Earnings Per Share (EPS)	$0.13
PE Ratio	58.46
Profit Margin	5.09%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	17.29%

How to invest in Lifecore Biomedical from India?

It is very easy for Indian residents to invest directly in Lifecore Biomedical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lifecore Biomedical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lifecore Biomedical or LFCR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lifecore Biomedical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lifecore Biomedical shares which would translate to 0.112 fractional shares of Lifecore Biomedical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lifecore Biomedical, in just a few clicks!

Returns in Lifecore Biomedical for Indian investors in Rupees

Investment Value

₹1,00,000

Lifecore Biomedical investment value today

Current value as on today

₹1,23,451

Returns

₹23,451

(+23.45%)

Returns from Lifecore Biomedical Stock

₹21,212 (+21.21%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Lifecore Biomedical

-8%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Lifecore Biomedical on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -8% less investors are searching Lifecore Biomedical in the last 30 days versus the previous period.

Global Institutional Holdings in Lifecore Biomedical

Wynnefield Capital Inc
13.36%
Legion Partners Asset Management, LLC
8.06%
Greenhaven Road Investment Management, L.P.
6.05%
22NW, LP
4.77%
BlackRock Inc
3.94%
325 Capital LLC
3.72%

Analyst Recommendation on Lifecore Biomedical

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Lifecore Biomedical(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Lifecore Biomedical

What analysts predicted

Upside of 5.26%

Current:

$7.60

Target:

$8.00

Insights on Lifecore Biomedical

Price Movement
In the last 3 months, LFCR stock has moved up by 61.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 37.88M → 24.70M (in $), with an average decrease of 34.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -7.08M → -16.23M (in $), with an average decrease of 129.1% per quarter

Lifecore Biomedical Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$557.6M	↑ 6.36%
Net Income	$2.1M	↓ 91.45%
Net Profit Margin	0.38%	↓ 4.36%

	FY20	Y/Y Change
Revenue	$590.4M	↑ 5.88%
Net Income	$-38.2M	↓ 1899.76%
Net Profit Margin	-6.47%	↓ 6.85%

	FY21	Y/Y Change
Revenue	$544.2M	↓ 7.83%
Net Income	$-32.7M	↓ 14.47%
Net Profit Margin	-6.0%	↑ 0.47%

	FY22	Y/Y Change
Revenue	$185.8M	↓ 65.86%
Net Income	$-97.4M	↑ 198.27%
Net Profit Margin	-52.44%	↓ 46.44%

	FY23	Y/Y Change
Revenue	$185.8M	↑ 0.0%
Net Income	$-46.1M	↓ 52.7%
Net Profit Margin	-24.8%	↑ 27.64%

	FY24	Y/Y Change
Revenue	$128.3M	↓ 30.96%
Net Income	$12.0M	↓ 126.07%
Net Profit Margin	9.37%	↑ 34.17%

	Q2 FY23	Q/Q Change
Revenue	$27.6M	↓ 42.05%
Net Income	$-15.5M	↓ 57.61%
Net Profit Margin	-56.02%	↑ 20.56%

	Q3 FY23	Q/Q Change
Revenue	$24.5M	↓ 11.15%
Net Income	$-10.8M	↓ 30.44%
Net Profit Margin	-43.85%	↑ 12.17%

	Q4 FY23	Q/Q Change
Revenue	$30.2M	↑ 22.95%
Net Income	$14.2M	↓ 232.21%
Net Profit Margin	47.16%	↑ 91.01%

	Q1 FY24	Q/Q Change
Revenue	$31.5M	↑ 4.63%
Net Income	$-36.1M	↓ 354.11%
Net Profit Margin	-114.53%	↓ 161.69%

	Q2 FY24	Q/Q Change
Revenue	$37.9M	↑ 20.1%
Net Income	$-7.1M	↓ 80.4%
Net Profit Margin	-18.7%	↑ 95.83%

	Q3 FY24	Q/Q Change
Revenue	$24.7M	↓ 34.79%
Net Income	$-16.2M	↑ 129.14%
Net Profit Margin	-65.7%	↓ 47.0%

	FY19	Y/Y Change
Profit	$81.0M	↑ 3.4%

	FY20	Y/Y Change
Profit	$75.0M	↓ 7.43%

	FY21	Y/Y Change
Profit	$81.5M	↑ 8.65%

	FY22	Y/Y Change
Profit	$50.4M	↓ 38.18%

	FY23	Y/Y Change
Profit	$50.6M	↑ 0.36%

	FY24	Y/Y Change
Profit	$41.9M	↓ 17.22%

	Q2 FY23	Q/Q Change
Profit	$6.0M	↓ 48.05%

	Q3 FY23	Q/Q Change
Profit	$2.7M	↓ 54.37%

	Q4 FY23	Q/Q Change
Profit	$10.0M	↑ 264.99%

	Q1 FY24	Q/Q Change
Profit	$8.4M	↓ 15.73%

	Q2 FY24	Q/Q Change
Profit	$17.3M	↑ 105.84%

	Q3 FY24	Q/Q Change
Profit	$5.4M	↓ 68.81%

	FY19	Y/Y Change
Operating Cash Flow	$16.0M	↓ 19.01%
Investing Cash Flow	$-96.8M	-
Financing Cash Flow	$79.0M	↑ 494.54%

	FY20	Y/Y Change
Operating Cash Flow	$-17.0M	↓ 206.37%
Investing Cash Flow	$-23.9M	↓ 75.32%
Financing Cash Flow	$40.0M	↓ 49.36%

	FY21	Y/Y Change
Operating Cash Flow	$15.0M	↓ 188.12%
Investing Cash Flow	$-10.9M	↓ 54.55%
Financing Cash Flow	$-3.4M	↓ 108.54%

	FY22	Y/Y Change
Operating Cash Flow	$-24.4M	↓ 262.48%
Investing Cash Flow	$81.8M	↓ 853.21%
Financing Cash Flow	$-57.0M	↑ 1567.77%

	FY23	Y/Y Change
Operating Cash Flow	$-24.4M	↑ 0.0%
Investing Cash Flow	$-4.2M	↓ 105.08%
Financing Cash Flow	$-57.0M	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-12.7M	↓ 35345.42%
Investing Cash Flow	$6.4M	↓ 296.56%
Financing Cash Flow	$6.1M	↓ 68.22%

Lifecore Biomedical Technicals Summary

Sell

Neutral

Buy

Lifecore Biomedical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Lifecore Biomedical Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lifecore Biomedical Inc	2.15%	47.86%	21.21%	-31.78%	-31.96%
Neurocrine Biosciences Inc.	6.74%	1.65%	2.84%	61.59%	27.41%
Haleon Plc Spon Ads	1.56%	15.54%	17.63%	31.44%	31.44%
Zoetis Inc.	-6.26%	-6.66%	-16.35%	-33.19%	24.57%
Viatris Inc.	-5.2%	18.32%	15.13%	-9.29%	-24.11%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lifecore Biomedical Inc	58.46	58.46	3.51	0.41	0.17	-0.02	NA	-0.13
Neurocrine Biosciences Inc.	36.41	36.41	0.32	6.37	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	29.52	29.52	1.76	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.96	30.96	2.56	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lifecore Biomedical Inc	Sell	$279.9M	-31.96%	58.46	5.09%
Neurocrine Biosciences Inc.	Buy	$13.8B	27.41%	36.41	17.21%
Haleon Plc Spon Ads	Buy	$44.0B	31.44%	29.52	10.75%
Zoetis Inc.	Buy	$74.3B	24.57%	30.96	26.55%
Viatris Inc.	Hold	$14.8B	-24.11%	224.4	-5.87%

About Lifecore Biomedical

landec corporation (nasdaq:lndc) is a leading innovator of diversified health and wellness solutions within the packaged food and biomaterial markets. apio, landec's food business, is the leader in branded, packaged fresh vegetables in north america, utilizing its proprietary breatheway® packaging technology to naturally extend the shelf life of fresh produce. apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the eat smart® brand to consumers through club and retail grocery stores. lifecore biomedical, landec's biomaterial business, is a fully integrated contract development and manufacturing organization (cdmo) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for fda regulated medical devices and drugs to customers for applications in a wide array of markets including ophthalmic, orthopedic and oncology. for more information abo

Organization	Lifecore Biomedical
Employees	524
CEO	Mr. Paul Josephs
Industry	Healthcare

Management People of Lifecore Biomedical

Name	Title
Mr. Paul Josephs	President, CEO & Director
Mr. James G. Hall	Advisor
Mr. Ryan D. Lake CPA	CFO & Secretary
Mr. Aaron Perlitsh	Director of Internal Audit & Chief Compliance Officer
Mr. Darren M. Hieber	Senior Vice President of Corporate Development & Partnerships
Ms. Brikkelle Thompson	Senior Vice President of Human Resources
Ms. Jackie Q. Klecker	Executive VP, Quality and Development Services & GM
Mr. Matt Augustson	Senior Vice President of Information Technology
Dr. Albert D. Bolles Ph.D.	President of Curation Foods, Inc.
Mr. Parker K. Javid	Vice President

Important FAQs about investing in Lifecore Biomedical from India :

What is Lifecore Biomedical share price today?

Lifecore Biomedical share price today stands at $7.60, Open: $7.13 ; Previous Close: $7.03 ; High: $7.63 ; Low: $6.93 ; 52 Week High: $8.90 ; 52 Week Low: $3.68. The stock opens at $7.13, after a previous close of $7.03. The stock reached a daily high of $7.63 and a low of $6.93, with a 52-week high of $8.90 and a 52-week low of $3.68.

Can Indians buy Lifecore Biomedical shares?

Yes, Indians can invest in the Lifecore Biomedical (LFCR) from India.

With INDmoney, you can buy Lifecore Biomedical at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Lifecore Biomedical at zero transaction cost.

How can I buy Lifecore Biomedical shares from India?

It is very easy to buy Lifecore Biomedical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lifecore Biomedical be purchased?

Yes, you can buy fractional shares of Lifecore Biomedical with INDmoney app.

What are the documents required to start investing in Lifecore Biomedical stocks?

To start investing in Lifecore Biomedical, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.